Background: Wolffian ducts (WDs) are the embryonic precursors of the male reproductive tract. Their development is induced by testosterone, which interacts with the androgen receptor (AR). The molecular pathways underlying androgen-dependent WD development are largely unknown. We aimed to identify AR target genes important in this process. Methods: RNA was isolated from rat WDs at E17.5 and E20.5. Affymetrix GeneChip expression arrays were used to identify transcripts up- or downregulated more than 2-fold. Regulation of seven transcripts was confirmed using quantitative PCR. Results: Transcripts from 76 known genes were regulated, including modulators of insulin-like growth factor and transforming growth factor-βsignalling. By controlling these modulators, androgens may indirectly affect growth factor signalling pathways important in epithelial–mesenchymal interactions and organ development. Caveolin-1, also upregulated, may play a role in modifying as well as mediating AR signalling. Differentiation of WD epithelium and smooth muscle, innervation and extracellular matrix synthesis were reflected in regulation of other transcripts. Several genes were previously suggested to be regulated by androgens or contained functional or putative androgen/glucocorticoid response elements, indicating they may be direct targets of androgen signalling. Conclusion: Our results suggest novel cohorts of signals that may contribute to androgen-dependent WD development and provide hypotheses that can be tested by future studies.

Keywords:
Testosterone, Wolffian duct, Androgen receptor, Microarray
1.
Jost A: Problems or fetal endocrinology: the gonadal and hypophyseal hormones. Recent Prog Horm Res 1953;8:379–418.
2.
Hannema SE, Scott IS, Hodapp J, Martin H, Coleman N, Schwabe JW, Hughes IA: Residual activity of mutant androgen receptors explains Wolffian duct development in the complete androgen insensitivity syndrome. J Clin Endocrinol Metab 2004;89:5815–5822.
3.
Bentvelsen FM, Brinkmann AO, van der Schoot P, van der Linden JETM, van der Kwast TH, Boersma WJA, Schröder FH, Nijman JM: Developmental pattern and regulation by androgens of androgen receptor expression in the urogenital tract of the rat. Mol Cell Endocrinol 1995;113:245–253.
4.
Cunha GR, Young P: Inability of Tfm (testicular feminization) epithelial cells to express androgen-dependent seminal vesicle secretory proteins in chimeric tissue recombinants. Endocrinology 1991;128:3293–3298.
5.
Huhtaniemi I: Fetal testis – a very special endocrine organ. Eur J Endocrinol 1994;130:25–31.
6.
Evans AL, Sharkey AS, Saidi SA, Print CG, Catalano RD, Smith SK, Charnock-Jones DS: Generation and use of a tailored gene array to investigate vascular biology. Angiogenesis 2003;6:93–104.
7.
Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP: Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 2003;31:e15.
8.
Grabe N: Alibaba2: context specific identification of transcription factor binding sites. In Silico Biol 2002;2:S1–S15.
9.
Garay-Rojas E, Harper M, Hraba-Renevey S, Kress M: An apparent autocrine mechanism amplifies the dexamethasone- and retinoic acid-induced expression of mouse lipocalin-encoding gene 24p3. Gene 1996;170:173–180.
10.
Umar A, Ooms MP, Luider TM, Grootegoed JA, Brinkmann AO: Proteomic pro- filing of epididymis and vas deferens: identification of proteins regulated during rat genital tract development. Endocrinology 2003;144:4637–4647.
11.
Umar A, Luider TM, Berrevoets CA, Grootegoed JA, Brinkmann AO: Proteomic analysis of androgen-regulated protein expression in a mouse fetal vas deferens cell line. Endocrinology 2003;144:1147–1154.
12.
Turner KJ, McIntyre BS, Phillips SL, Barlow NJ, Bowman CJ, Foster PMD: Altered gene expression during rat Wolffian duct development in response to in uteroexposure to the anti-androgen linuron. Toxicol Sci 2003;74:114–128.
13.
Lu ML, Schneider MC, Zheng Y, Zhang X, Richie JP: Caveolin-1 interacts with androgen receptor. A positive modulator of androgen receptor mediated transactivation. J Biol Chem 2001;276:13442–13451.
14.
Li L, Yang G, Ebara S, Satoh T, Nasu Y, Timme TL, Ren C, Wang J, Tahir SA, Thompson TC: Caveolin-1 mediates testosterone-stimulated survival/clonal growth and promotes metastatic activities in prostate cancer cells. Cancer Res 2001;61:4386–4392.
15.
Baker J, Hardy MP, Zhou J, Bondy C, Lupu F, Bellvé AR, Efstratiadis A: Effects of an Igf1 gene null mutation on mouse reproduction. Mol Endocrinol 1996;10:903–918.
16.
Zumbrunn J, Trueb B: Localization of the gene for a serine protease with IGF-binding domain (PRSS11) to human chromosome 10q25.3-q26.2. Genomics 1997;45:461–462.
17.
Rowley DR, Dang TD, Larsen M, Gerdes MJ, McBride L, Lu B: Purification of a novel protein (ps20) from urogenital sinus mesenchymal cells with growth inhibitory properties in vitro. J Biol Chem 1995;270:22058–22065.
18.
Larsen M, Ressler SJ, Lu B, Gerdes MJ, McBride L, Dang TD, Rowley DR: Molecular cloning and expression of ps20 growth inhibitor. A novel WAP-type ‘four-disulfide core’ domain protein expressed in smooth muscle. J Biol Chem 1998;273:4574–4584.
19.
Sanford LP, Ormsby I, Gittenberger-de Groot AC, Sariola H, Friedman R, Boivin GP, Cardell EL, Doetschman T: TGFβ2 knockout mice have multiple developmental defects that are non-overlapping with other TGFβknockout phenotypes. Development 1997;124:2659–2670.
20.
Stenvers KL, Tursky ML, Harder KW, Kountouri N, Amatayakul-Chantler S, Grail D, Small C, Weinberg RA, Sizeland AM, Zhu HJ: Heart and liver defects and reduced transforming growth factor β2 sensitivity in transforming growth factor βtype III receptor-deficient embryos. Mol Cell Biol 2003;23:4371–4385.
21.
Okamoto O, Fujiwara S, Abe M, Sato Y: Dermatopontin interacts with transforming growth factor βand enhances its biological activity. Biochem J 1999;337:537–541.
22.
Vij N, Roberts L, Joyce S, Chakravarti S: Lumican suppresses cell proliferation and aids Fas-Fas ligand mediated apoptosis: implications in the cornea. Exp Eye Res 2004;78:957–971.
23.
Oka C, Tsujimoto R, Kajikawa M, Koshiba-Takeuchi K, Ina J, Yano M, Tsuchiya A, Ueta Y, Soma A, Kanda H, Matsumoto M, Kawaichi M: HtrA1 serine protease inhibits signaling mediated by Tgfβfamily proteins. Development 2004;131:1041–1053.
24.
Moussad EEDA, Brigstock DR: Connective tissue growth factor: what’s in a name? Mol Genet Metab 2000;71:276–292.
25.
Kireeva ML, Latinkíc BV, Kolesnikova TV, Chen CC, Yang GP, Abler AS, Lau LF: Cyr61 and Fisp12 are both ECM-associated signaling molecules: activities, metabolism, and localization during development. Exp Cell Res 1997;233:63–77.
26.
Thomson AA: Role of androgens and fibroblast growth factors in prostatic development. Reproduction 2001;121:187–195.
27.
Miyazaki M, Ohashi R, Tsuji T, Mihara K, Gohda E, Namba M: Transforming growth factor-β1 stimulates or inhibits cell growth via down- or up-regulation of p21/Waf1. Biochem Biophys Res Commun 1998;246:873–880.
28.
Gakunga P, Frost G, Shuster S, Cunha G, Formby B, Stern R: Hyaluronan is a prerequisite for ductal branching morphogenesis. Development 1997;124:3987–3997.
29.
Veräjänkorva E, Pöllänen P, Hänninen A, Martikainen M, Sundström J, Antola H: IL-10 is highly expressed in the cryptorchid cryptepididymal epithelium: a probable mechanism preventing immune responses against autoantigenic spermatozoa in the epididymal tubule. Int J Androl 2002;25:129–133.
30.
Tammi R, Rönkkö S, Ågren UM, Tammi M: Distribution of hyaluronan in bull reproductive organs. J Histochem Cytochem 1994;42:1479–1486.
31.
Sherman L, Wainwright D, Ponta H, Herrlich P: A splice variant of CD44 expressed in the apical ectodermal ridge presents fibroblast growth factors to limb mesenchyme and is required for limb outgrowth. Genes Dev 1998;12:1058–1071.
32.
Chua SS, Ma Z, Gong L, Lin S, DeMayo FJ, Tsai SY: Ectopic expression of FGF-3 results in abnormal prostate and Wolffian duct development. Oncogene 2002;21:1899–1908.
33.
Fujishige A, Takahashi K, Tsuchiya T: Altered mechanical properties in smooth muscle of mice with a mutated calponin locus. Zoolog Sci 2002;19:167–174.
34.
Woodman SE, Cheung MW, Tarr M, North AC, Schubert W, Lagaud G, Marks CB, Russell RG, Hassan GS, Factor SM, Christ GJ, Lisanti MP: Urogenital alterations in aged male caveolin-1 knockout mice. J Urol 2004;171:950–957.
35.
Chang DF, Belaguli NS, Iyer D, Roberts WB, Wu SP, Dong XR, Marx JG, Moore MS, Beckerle MC, Majesky MW, Schwartz RJ: Cysteine-rich LIM-only proteins CRP1 and CRP2 are potent smooth muscle differentiation cofactors. Dev Cell 2003;4:107–118.
36.
Vlahopoulos S, Zimmer WE, Jenster G, Belaguli NS, Balk SP, Brinkmann AO, Lanz RB, Zoumpourlis VC, Schwartz RJ: Recruitment of the androgen receptor via serum response factor facilitates expression of a myogenic gene. J Biol Chem 2005;280:7786–7792.
37.
Shughrue PJ, Dorsa DM: Estrogen and androgen differentially modulate the growth-associated protein GAP-43 (neuromodulin) messenger ribonucleic acid in postnatal rat brain. Endocrinology 1994;134:1321–1328.
38.
Jiang F, Wang Z: Identification of androgen-responsive genes in the rat ventral prostate by complementary deoxyribonucleic acid subtraction and microarray. Endocrinology 2003;144:1257–1265.
39.
Ezer N, Robaire B: Gene expression is differentially regulated in the epididymis after orchidectomy. Endocrinology 2003;144:975–988.
40.
Assisi L, Autuori F, Botte V, Farrace MG, Piacentini M: Hormonal control of ‘tissue’ transglutaminase induction during programmed cell death in frog liver. Exp Cell Res 1999;247:339–346.
41.
Falls JG, Ryu D, Cao Y, Levi PE, Hodgson E: Regulation of mouse liver flavin-containing monooxygenases 1 and 3 by sex steroids. Arch Biochem Biophys 1997;342:212–223.
42.
Gori F, Hofbauer LC, Conover CA, Khosla S: Effects of androgens on the insulin-like growth factor system in an androgen-responsive human osteoblastic cell line. Endocrinology 1999;140:5579–5586.
43.
Chang CS, Saltzman AG, Sorensen NS, Hiipakka RA, Liao SS: Identification of glutathione S-transferase Yb1 mRNA as the androgen-repressed mRNA by cDNA cloning and sequence analysis. J Biol Chem 1987;262:11901–11903.
44.
Del Monaco M, Covello SP, Kennedy SH, Gilinger G, Litwack G, Uitto J: Identification of novel glucocorticoid-response elements in human elastin promoter and demonstration of nucleotide sequence specificity of the receptor binding. J Invest Dermatol 1997;108:938–942.
45.
Renkawitz R, Schütz G, von der Ahe D, Beato M: Sequences in the promoter region of the chicken lysozyme gene required for steroid regulation and receptor binding. Cell 1984;37:503–510.
46.
Rhodes C, Yamada Y: Characterization of a glucocorticoid responsive element and identification of an AT-rich element that regulate the link protein gene. Nucleic Acids Res 1995;23:2305–2313.
47.
Chandrasekhar S, Souba WW, Abcouwer SF: Identification of glucocorticoid-responsive elements that control transcription of rat glutamine synthetase. Am J Physiol 1999;276:L319–L331.
48.
Liu Y, Nakagawa Y, Toya K, Saegusa H, Nasuda K, Endoh A, Ohzeki T: Effects of thyroid hormone (thyroxine) and testosterone on hepatic 11β-hydroxysteroid dehydrogenase mRNA and activity in pubertal hypothyroid male rats. Metabolism 1998;47:474–477.
© 2006 S. Karger AG, Basel
2006
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.